New research from Norman Fixel and UF Health collaborators👨‍⚕️👩‍⚕️ reveals a promising link between GLP-1 receptor agonists and a reduced risk of Parkinson's in older adults with type 2 diabetes. The study found a 23% lower risk of PD among GLP-1RA users compared to DPP4i users. Exciting potential for future treatments! #ParkinsonsResearch #DiabetesCare Full Study: movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29992